BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26907527)

  • 21. Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors.
    Cao W; Liu J; Wang L; Li M; Verstegen MMA; Yin Y; Ma B; Chen K; Bolkestein M; Sprengers D; van der Laan LJW; Doukas M; Kwekkeboom J; Smits R; Peppelenbosch MP; Pan Q
    Carcinogenesis; 2019 Mar; 40(1):145-154. PubMed ID: 30289434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DNA methylation landscape of human cancer organoids available at the American type culture collection.
    Joshi R; Castro De Moura M; Piñeyro D; Alvarez-Errico D; Arribas C; Esteller M
    Epigenetics; 2020 Nov; 15(11):1167-1177. PubMed ID: 32396494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor organoids: applications in cancer modeling and potentials in precision medicine.
    Xu H; Jiao D; Liu A; Wu K
    J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can Organoid Model Reveal a Key Role of Extracellular Vesicles in Tumors? A Comprehensive Review of the Literature.
    Zhang Y; Lu A; Zhuang Z; Zhang S; Liu S; Chen H; Yang X; Wang Z
    Int J Nanomedicine; 2023; 18():5511-5527. PubMed ID: 37791321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3D modeling in cancer studies.
    Atat OE; Farzaneh Z; Pourhamzeh M; Taki F; Abi-Habib R; Vosough M; El-Sibai M
    Hum Cell; 2022 Jan; 35(1):23-36. PubMed ID: 34761350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
    Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
    Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
    Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Experimental Three-Dimensional Tumor Models to Study Glioblastoma Cancer Stem Cells and Tumor Microenvironment.
    Ruiz-Garcia H; Zarco N; Watanabe F; De Araujo Farias V; Suarez-Meade P; Guerrero-Cazares H; Imitola J; Quinones-Hinojosa A; Trifiletti D
    Methods Mol Biol; 2023; 2572():117-127. PubMed ID: 36161412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From organoids to bedside: Advances in modeling, decoding and targeting of colorectal cancer.
    Betge J; Jackstadt R
    Int J Cancer; 2023 Apr; 152(7):1304-1313. PubMed ID: 36121667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organoids in lung cancer: A teenager with infinite growth potential.
    Xu Y; Xin W; Yan C; Shi Y; Li Y; Hu Y; Ying K
    Lung Cancer; 2022 Oct; 172():100-107. PubMed ID: 36041323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-derived organoids as a model for tumor research.
    Wang J; Feng X; Li Z; Chen Y; Huang W
    Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organoids in recapitulating tumorigenesis driven by risk factors: Current trends and future perspectives.
    Zhang J; Wang L; Song Q; Xiao M; Gao J; Cao X; Zheng W
    Int J Biol Sci; 2022; 18(7):2729-2743. PubMed ID: 35541903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications of Organoids for Cancer Biology and Precision Medicine.
    Lo YH; Karlsson K; Kuo CJ
    Nat Cancer; 2020 Aug; 1(8):761-773. PubMed ID: 34142093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-Derived Organoids of Cholangiocarcinoma.
    Maier CF; Zhu L; Nanduri LK; Kühn D; Kochall S; Thepkaysone ML; William D; Grützmann K; Klink B; Betge J; Weitz J; Rahbari NN; Reißfelder C; Schölch S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer organoid co-culture model system: Novel approach to guide precision medicine.
    Yuan J; Li X; Yu S
    Front Immunol; 2022; 13():1061388. PubMed ID: 36713421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal, Large-Scale Propagation of Mouse Mammary Tumor Organoids.
    Wrenn ED; Moore BM; Greenwood E; McBirney M; Cheung KJ
    J Mammary Gland Biol Neoplasia; 2020 Dec; 25(4):337-350. PubMed ID: 33106923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture.
    Elbadawy M; Usui T; Mori T; Tsunedomi R; Hazama S; Nabeta R; Uchide T; Fukushima R; Yoshida T; Shibutani M; Tanaka T; Masuda S; Okada R; Ichikawa R; Omatsu T; Mizutani T; Katayama Y; Noguchi S; Iwai S; Nakagawa T; Shinohara Y; Kaneda M; Yamawaki H; Sasaki K
    Cancer Sci; 2019 Sep; 110(9):2806-2821. PubMed ID: 31254429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organoid Models for Precision Cancer Immunotherapy.
    Sun CP; Lan HR; Fang XL; Yang XY; Jin KT
    Front Immunol; 2022; 13():770465. PubMed ID: 35450073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.